Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Rosiello

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Annals of Translational Medicine|February 5, 2020
Acute kidney injury after partial nephrectomy: transient or permanent kidney damage?-Impact on long-term renal functionGiuseppe Rosiello, Umberto Capitanio, Alessandro Larcher
European Urology Oncology|October 14, 2023
Re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia
European Urology|April 24, 2026
Re: Antonio Franco, Francesco Ditonno, Celeste Manfredi, et al. Systematic Review and Pooled Analysis of Functional and Sexual Outcomes of Minimally Invasive Surgical Treatments for Benign Prostatic Obstruction. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.09.004Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia
Current Opinion in Urology|September 11, 2019
Salvage pelvic lymph node dissection for lymph node recurrent prostate cancerGiuseppe Rosiello, Marco Bandini, Alberto Briganti
Urologic Oncology|June 1, 2022
Reply to Sebastiano Buti and Giulia Claire Giudice's Letter to the Editor comparing the prognostic models to predict oncologic outcomes in patients with renal cell carcinoma: Is AUC close enough to clinical practice? Urol Oncol. 2022 Apr 14:S1078-1439(22)00066-7. doi: 10.1016/j.urolonc.2022.02.015Giuseppe Rosiello, Alessandro Larcher, Francesco Montorsi, et al.
European Urology|March 14, 2022
Re: Sarah P. Psutka, Roman Gulati, Michael A.S. Jewett, et al. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. Eur Urol. 2022;81:576-85Francesco Montorsi, Umberto Capitanio, Giuseppe Rosiello, et al.
European Urology Focus|May 25, 2021
Reply to Nikolaos Grivas and Henk G. van der Poel's Letter to the Editor re: Rui Farinha, Giuseppe Rosiello, Artur De Oliveira Paludo, et al. Selective Suturing or Sutureless Technique in Robot-assisted Partial Nephrectomy: Results from a Propensity-score Matched Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.019Rui Farinha, Giuseppe Rosiello, Stefano Puliatti, et al.
World Journal of Urology|August 12, 2021
Renal cancer: overdiagnosis and overtreatmentGiuseppe Rosiello, Alessandro Larcher, Francesco Montorsi, et al.
European Urology Focus|October 26, 2025
Re: Siamak Daneshmand, Michiel S. Van der Heijden, Joseph M. Jacob, et al. TAR-200 for Bacillus Calmette-Guérin-unresponsive High-risk Non-muscle-invasive Bladder Cancer: Results from the Phase IIb SunRISe-1 Study. J Clin Oncol. In press. https://doi.org/10.1200/jco-25-01651Francesco Montorsi, Marco Moschini, Giuseppe Rosiello, et al.
European Urology|February 28, 2025
Re: Valeria Panebianco, Alberto Briganti, Jason Efstathiou, et al. The Role of Multiparametric Magnetic Resonance Imaging and the Vesical Imaging-Reporting and Data System (VI-RADS) in the Management of Patients with Bladder Cancer: Vision of the American College of Radiology VI-RADS Steering Committee. Eur Urol 2024;86:485-7Francesco Montorsi, Giuseppe Rosiello, Pietro Scilipoti, et al.
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Annals of Translational Medicine|February 5, 2020
Acute kidney injury after partial nephrectomy: transient or permanent kidney damage?-Impact on long-term renal functionGiuseppe Rosiello, Umberto Capitanio, Alessandro Larcher
European Urology Oncology|October 14, 2023
Re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia
European Urology|April 24, 2026
Re: Antonio Franco, Francesco Ditonno, Celeste Manfredi, et al. Systematic Review and Pooled Analysis of Functional and Sexual Outcomes of Minimally Invasive Surgical Treatments for Benign Prostatic Obstruction. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.09.004Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia
Current Opinion in Urology|September 11, 2019
Salvage pelvic lymph node dissection for lymph node recurrent prostate cancerGiuseppe Rosiello, Marco Bandini, Alberto Briganti
Urologic Oncology|June 1, 2022
Reply to Sebastiano Buti and Giulia Claire Giudice's Letter to the Editor comparing the prognostic models to predict oncologic outcomes in patients with renal cell carcinoma: Is AUC close enough to clinical practice? Urol Oncol. 2022 Apr 14:S1078-1439(22)00066-7. doi: 10.1016/j.urolonc.2022.02.015Giuseppe Rosiello, Alessandro Larcher, Francesco Montorsi, et al.
European Urology|March 14, 2022
Re: Sarah P. Psutka, Roman Gulati, Michael A.S. Jewett, et al. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. Eur Urol. 2022;81:576-85Francesco Montorsi, Umberto Capitanio, Giuseppe Rosiello, et al.
European Urology Focus|May 25, 2021
Reply to Nikolaos Grivas and Henk G. van der Poel's Letter to the Editor re: Rui Farinha, Giuseppe Rosiello, Artur De Oliveira Paludo, et al. Selective Suturing or Sutureless Technique in Robot-assisted Partial Nephrectomy: Results from a Propensity-score Matched Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.019Rui Farinha, Giuseppe Rosiello, Stefano Puliatti, et al.
World Journal of Urology|August 12, 2021
Renal cancer: overdiagnosis and overtreatmentGiuseppe Rosiello, Alessandro Larcher, Francesco Montorsi, et al.
European Urology Focus|October 26, 2025
Re: Siamak Daneshmand, Michiel S. Van der Heijden, Joseph M. Jacob, et al. TAR-200 for Bacillus Calmette-Guérin-unresponsive High-risk Non-muscle-invasive Bladder Cancer: Results from the Phase IIb SunRISe-1 Study. J Clin Oncol. In press. https://doi.org/10.1200/jco-25-01651Francesco Montorsi, Marco Moschini, Giuseppe Rosiello, et al.
European Urology|February 28, 2025
Re: Valeria Panebianco, Alberto Briganti, Jason Efstathiou, et al. The Role of Multiparametric Magnetic Resonance Imaging and the Vesical Imaging-Reporting and Data System (VI-RADS) in the Management of Patients with Bladder Cancer: Vision of the American College of Radiology VI-RADS Steering Committee. Eur Urol 2024;86:485-7Francesco Montorsi, Giuseppe Rosiello, Pietro Scilipoti, et al.
Pageof 16